J&J R&D vet Pe­ter Tum­mi­no joins the Big Phar­ma ex­o­dus, leap­ing to Nim­bus as CSO; Ca­dent taps Jodie Mor­ri­son for CEO

→ Af­ter spend­ing the last 16 years as a re­searcher in Big Phar­ma, Pe­ter Tum­mi­no is go­ing biotech.

Nim­bus re­ports that Tum­mi­no is join­ing the com­pa­ny as its new CSO af­ter his last stint at J&J, where he was glob­al head of lead dis­cov­ery and head­ed up re­search teams on both sides of the At­lantic. Ear­li­er he had a long stretch at GSK, where he ran the can­cer epi­ge­net­ics team, among oth­er things.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER